FDA to Review Easing Restrictions on Peptides

Bloomberg 2026-06-21 16:17:14
Context: The US Food and Drug Administration (FDA) is set to review its restrictions on certain peptide injections this summer, amid encouragement from Robert F. Kennedy Jr. (RFK Jr.) and the Trump administration. Peptides have gained popularity among wellness enthusiasts and biohackers, who claim they offer various health benefits. The review comes as the FDA faces pressure to reconsider its stance on these substances.

Key Facts

  • The FDA will consider loosening restrictions on certain peptide injections this summer, a move that has been encouraged by RFK Jr. and the Trump administration.
  • Peptides are popular among wellness enthusiasts and biohackers, who claim they offer benefits ranging from treating tendonitis to enhancing tanning.
  • Bloomberg Businessweek senior reporter Amanda Mull explained the development to hosts David Gura and Christina Ruffini in a video report.
  • The peptides in question are being promoted for various health benefits, despite a lack of clear evidence supporting their efficacy or safety.
  • The FDA's review of peptide restrictions reflects a broader debate about the regulation of substances used for wellness and self-improvement purposes.

Summarised in seconds by Grasp AI

Cut out the noise. Build your own custom factual news feed for free, or summarise any article instantly.

Create your free dashboard